Bisdemethoxycurcumin inhibits Wnt/β-catenin pathway by increasing WIF-1 expression, which subsequently leads to suppression of TGF-β1-induced EMT migration. - GreenMedInfo Summary
Abstract Title:
Abstract Source:
Abstract:
Study Type : In Vitro Study
Additional Links
Diseases : Carcinoma: Non-Small-Cell Lung : CK(264) : AC(161), Lung Cancer : CK(1741) : AC(742), Lung Cancer: Metastatic : CK(40) : AC(15)
Pharmacological Actions : Anti-metastatic : CK(1284) : AC(927), Wnt/β-catenin pathway down-regulation : CK(49) : AC(27)